Skip to main content

Table 2 Demographic, laboratory and outcome information of 375 samples in training dataset

From: Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning

Characteristicsa

Statisticsb

Characteristicsa

Statisticsb

Demographics

 

Outcomes

 

Age, mean (years)

58.83

Survival, count and rate

201, 53.6%

Gender

Male 224; Female 151

Mortality, count and rate

174, 46.4%

Lab test mean (min, max) patient’s last measurements

 cTnI

747.76 (1.9, 43,905.19)

glucose

8.37 (2.43, 32.37)

 Hemoglobin

124.89 (6.4, 178.0)

neutrophils count

7.03 (0.85, 31.43)

 Serum chloride

102.73 (77.7, 138.2)

Direct bilirubin

9.5 (1.7, 216.3)

 Prothrombin time

16.01 (11.69, 84.22)

Mean platelet volume

10.89 (9.04, 14.0)

 procalcitonin

0.99 (0.02, 49.34)

ferritin

1634.37 (26.8, 42,402.91)

 Eosinophils(%)

0.56 (0.0, 5.61)

RBCW-SD

41.78 (32.5, 83.3)

 sIL-2R

961.52 (61.0, 5608.04)

Thrombin time

18.17 (13.0, 133.67)

 Alkaline phosphatase

84.86 (37.18, 481.5)

Lymphocyte(%)

16.45 (0.6, 54.83)

 albumin

33.06 (19.1, 45.07)

Anti-HCV

0.13 (0.03, 1.85)

 basophil(%)

0.21 (0.0, 1.38)

D-D dimer

6.2 (0.21, 29.82)

 Interleukin 10

12.5 (5.0, 500.0)

Total cholesterol

3.66 (0.66, 6.11)

 Total bilirubin

16.28 (2.95, 276.0)

AST

56.53 (8.0, 1858.0)

 Platelet count

187.78 (1.2, 472.5)

Uric acid

297.47 (57.0, 1001.0)

 monocytes(%)

6.66 (0.62, 31.62)

HCO3-

22.59 (6.3, 29.7)

 antithrombin

87.57 (20.0, 136.0)

calcium

2.1 (1.35, 2.5)

 Interleukin 8

88.08 (5.0, 6385.85)

NT-proBNP

3166.26 (5.57, 70,000.0)

 indirect bilirubin

6.85 (1.0, 79.3)

LDH

492.12 (143.0, 1867.0)

 RDW

12.94 (10.91, 22.91)

platelet large cell ratio

31.63 (16.48, 54.1)

 Neutrophils(%)

76.09 (15.9, 98.1)

Interleukin 6

130.37 (1.5, 5000.0)

 Total protein

66.06 (36.7, 79.33)

FDP

44.29 (4.0, 182.4)

 Anti-TP

0.17 (0.02, 8.74)

monocytes count

0.54 (0.08, 22.75)

 Prothrombin activity

80.97 (16.3, 136.64)

PLT distribution width

12.97 (8.42, 25.3)

 HBsAg

10.35 (0.0, 250.0)

globulin

32.96 (13.8, 46.04)

 mean corpuscular volume

89.75 (62.3, 110.73)

γ-GT

51.79 (10.6, 555.25)

 hematocrit

37.0 (19.9, 51.3)

INR

1.3 (0.86, 10.51)

 WBC

15.18 (0.8, 1726.6)

basophil count(#)

0.02 (0.0, 0.12)

 Tumor necrosis factorα

12.07 (4.0, 168.0)

2019-nCoV nucleic acid

−1.0 (−1.0, −1.0)

 MCHC

344.17 (286.0, 464.33)

MCH

30.9 (20.8, 47.67)

 fibrinogen

4.38 (0.5, 8.89)

APTT

41.72 (25.59, 100.27)

 Interleukin 1β

6.56 (5.0, 79.44)

hs-CRP

72.49 (0.2, 320.0)

 Urea

9.74 (2.17, 68.4)

anti-HIV

0.1 (0.05, 0.26)

 lymphocyte count

1.06 (0.13, 35.53)

serum sodium

141.06 (122.8, 171.4)

 PH value

6.47 (5.0, 7.54)

thrombocytocrit

0.21 (0.05, 0.49)

 Red blood cell count

7.58 (0.1, 749.5)

ESR

32.33 (2.0, 102.0)

 Eosinophil count

0.03 (0.0, 0.33)

GPT

42.6 (5.0, 1508.0)

 Corrected calcium

2.34 (1.78, 2.67)

eGFR

81.07 (2.0, 164.7)

 Serum potassium

4.45 (3.1, 9.86)

creatinine

120.38 (39.25, 1497.0)

  1. aCharacteristics have three types - demographics (age and gender), outcomes (survival and mortality) and laboratory test (74 items)
  2. b Statistics is statistical data for corresponding characteristics, such as rate, mean value and range. The statistical methods are described in each column